Volume Alert - AMZN 327.89 Amazon.Com Inc $AMZN Hit a high

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - AMZN 327.89 Amazon.Com Inc $AMZN Hit a high today of 329.56 Closing the day 10:30 at 327.89 +4.84 +1.50% With a day low of 323.25 and a total volume of 1,222,451.

AMZN Recent Posts: http://investorshangout.com/Amazoncom-Inc-AMZN-53324/

AMZN Amazon.Com Inc Recent Headline News

3 Services Stocks Driving The Sector Higher
at The Street - 1 hr 29 mins ago
TheStreet highlights 3 stocks pushing the services sector higher today.
AMZN: 325.83 (+2.78), DAL: 44.67 (+1.24), WAG: 67.78 (+1.23)

Jim Cramer: Which Stocks Stand Out as Winners? Here's My List
at The Street - 1 hr 45 mins ago
There's a powerful collection of 'what's working.'
HON: 96.79 (+0.26), JAH: 66.87 (+0.18), CAH: 80.68 (+0.32), WMT: 83.70 (+0.13), PDCO: 46.75 (+0.49), EAT: 54.01 (+0.05), UPS: 106.35 (-0.12), JACK: 71.25 (+0.96), DLTR: 61.97 (+0.50), TGT: 66.77 (-0.36), COST: 138.94 (+0.47), AAL: 44.87 (+1.18), DG: 65.75 (+0.45), LOW: 58.27 (-0.62), MSFT: 48.87 (-0.59), HSIC: 131.87 (+0.93), BCR: 166.80 (+1.99), MCK: 206.20 (+1.82), IP: 54.97 (+0.13), EW: 127.25 (+1.02), FDO: 78.91 (+0.05), AZO: 569.15 (+1.09), MCD: 96.38 (+0.41), SHW: 240.00 (+0.69), XRAY: 53.02 (+0.41), AN: 57.73 (+0.39), F: 15.50 (-0.04), ACT: 266.35 (+18.41), BDX: 130.31 (+0.77), VRX: 141.81 (+5.08), MDT: 71.76 (+2.57), SNA: 136.05 (+1.16), GMCR: 157.34 (+2.84), AGN: 213.77 (+4.57), KMX: 55.35 (+0.69), YHOO: 52.02 (-0.35), WHR: 177.28 (+1.73), CMG: 657.79 (-0.53), AAPL: 115.37 (+1.38), AMZN: 325.83 (+2.78), HD: 96.48 (-1.55), ORLY: 178.57 (+1.27), FRGI: 56.12 (+0.46), ABC: 89.54 (+0.53), TJX: 60.55 (-0.99), GM: 32.34 (+0.03), JWN: 73.15 (-0.12), ROST: 80.69 (-0.65)

Would Amazon Benefit From A More Focused Approach?
Healthy Appreciation - at Seeking Alpha - 2 hrs 34 mins ago

AMZN: 325.83 (+2.78)

Verizon FiOS Cord-Cutter Deal Adds Netflix, HBO
at Investor's Business Daily - Tue Nov 18, 8:27AM CST
Verizon Communications (VZ) is targeting cable TV cord cutters with an aggressive Q4 broadband-first/TV-light promotion that analysts expect will boost its FiOS subscriber additions. For $60 a month, Verizon's new offering provides 50 megabits per...
NFLX: 384.11 (+2.97), AMZN: 325.83 (+2.78), T: 35.72 (-0.13), DISCA: 33.48 (+0.95), DIS: 90.43 (+0.02), CMCSA: 54.31 (+0.16), VZ: 51.25 (-0.15), TWX: 80.33 (-0.07)

Today's Market: Japanese Economic Moves, Earnings And Corporate News
Matthew Smith - at Seeking Alpha - Tue Nov 18, 8:20AM CST

GPRO: 85.58 (+4.08), AMZN: 325.83 (+2.78), HD: 96.48 (-1.55), MSFT: 48.87 (-0.59), CSCO: 26.65 (+0.18)

Michael Khouw of Action Alerts OPTIONS: A Bull Case for Office Depot
at The Street - Tue Nov 18, 8:16AM CST
This potential merger candidate looks attractive for the long term.
SPLS: 12.77 (-0.20), MMM: 159.63 (+0.94), AMZN: 325.83 (+2.78), NWL: 35.60 (-0.02), IP: 54.97 (+0.13), TGT: 66.77 (-0.36), WMT: 83.70 (+0.13), ODP: 6.72 (+0.03), MSFT: 48.87 (-0.59), HPQ: 37.68 (+0.27)

Audible Studios Releases Original Audio Drama by Jeffery Deaver, The Starling Project
Business Wire - Tue Nov 18, 8:01AM CST
Audible, Inc., the world's largest seller and producer of downloadable audiobooks and other spoken-word content, today announced the release of an original audiobook written by New York Times bestselling author Jeffery Deaver, entitled The Starling Project. Deaver's dramatic, dialogue-driven, edge-of-your-seat adventure takes listeners from Mexico to Marseille to Prague as a war crimes investigator and his team pursues a mysterious mastermind, bent on destruction, known only as The Starling. Written exclusively for Audible, The Starling Project is available for download at www.audible.com/StarlingProject.
AMZN: 325.83 (+2.78)

Google Chromecast vs. Amazon Fire TV Stick: Which Should You Choose?
Daniel Kline, The Motley Fool - Motley Fool - Tue Nov 18, 7:43AM CST
Amazon.com   clearly targeted  Google 's   Chromecast when it released the Fire TV Stick. The tiny digital streaming players have similar profiles, the same basic functionality, and comparable prices. Both devices also offer the same basic suite...
NFLX: 384.11 (+2.97), AMZN: 325.83 (+2.78), GOOGL: 545.97 (-0.67), GOOG: 535.21 (-1.30)

Update: Amazon Ends Dispute With Hachette; The Deal Is The Opposite Of My Predictions
ColoradoWealthManagementFund - at Seeking Alpha - Tue Nov 18, 6:54AM CST

AMZN: 325.83 (+2.78)

'Fast Money' Recap: Stay Short the Yen Following Japan's GDP Miss
at The Street - Tue Nov 18, 4:00AM CST
The trading panel discussed Japan's surprising announcement and whether Twitter is a better bet than Facebook or LinkedIn.
CST: 42.69 (+0.78), AMZN: 325.83 (+2.78), GE: 26.91 (+0.30), FB: 74.51 (+0.27), HAL: 49.06 (-0.17), WMT: 83.70 (+0.13), TLT: 119.47 (+0.28), SLB: 95.70 (+0.07), LNKD: 223.18 (-0.10), SUNE: 20.96 (+4.35), TGT: 66.77 (-0.36), CVS: 90.16 (+0.04), GOOGL: 545.97 (-0.67), TWTR: 40.27 (-0.20), GDX: 20.11 (+0.72), BHI: 64.71 (-0.52)

JD.com Q3 Tops Estimates But Outlook Fails To Excite
at Investor's Business Daily - Mon Nov 17, 5:16PM CST
China e-tailer JD.com early Monday reported better-than-expected third quarter earnings, as its active user base more than doubled from the year-earlier period. JD.com (JD) reported revenue of $4.71 billion, up 61% in local currency. That was above...
AMZN: 325.83 (+2.78), JD: 25.30 (+0.30), BABA: 111.69 (-2.56)

5 Ways SodaStream International, Ltd. Is Trying to Reinvent Itself
Isaac Pino, CPA, The Motley Fool - Motley Fool - Mon Nov 17, 4:36PM CST
SodaStream's new logo, emphasizing water over cola. Source: SodaStream. Do-it-yourself soda company SodaStream recently announced that earnings took a 41% year-over-year nosedive for the third quarter of 2014. And this wasn't a one-off...
KO: 42.83 (-0.09), YHOO: 52.01 (-0.36), AMZN: 325.83 (+2.78), SODA: 22.69 (+0.01), PEP: 97.94 (-0.48)

Distressing Time for U.S. Pay-TV as Customer Churn Soars - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 3:48PM CST
Research firm Leichtman Research Group recently reported that 13 major U.S. pay-TV operators lost a total of about 150,000 subscribers in the third quarter of 2014.
NFLX: 384.11 (+2.97), AMZN: 325.83 (+2.78), T: 35.72 (-0.13), CHTR: 155.71 (+0.40), DTV: 87.30 (+0.39), TWC: 141.84 (+0.07), CMCSA: 54.31 (+0.16), VZ: 51.25 (-0.15), CVC: 18.96 (+0.27), DISH: 65.96 (+0.68)

Amazon (AMZN) Continues to Gain on Hachette e-Book Deal
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading